Minneapolis, MN – According to filings with the U.S. Securities and Exchange Commission, Pelvital USA is raising $5,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Dale Wahlstrom played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Pelvital USA

Flyte is a simple, effective bladder leak treatment for stress urinary incontinence (SUI), designed to strengthen and treat weakened pelvic floor muscles to substantially improve bladder leaks when used as directed for 5 minutes per day for 6 weeks, the standard treatment time. Use Flyte at home without a prescription!  Flyte promotes a healing response within the cells of the pelvic floor muscles, restoring strength and bladder control. This is called mechanotherapy  the Flyte wand, mechanical pulses and muscle contractions working together to restore your pelvic floor.

To learn more about Pelvital USA, visit http://flytetherapy.com/

Contact:
Dale Wahlstrom, Chief Executive Officer
866-735-8482
https://www.linkedin.com/in/dale-wahlstrom-22410a3/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved